Best Practices in the Assessment and Management of Chronic Pain (PHYSICIANS)
Best Practices in the Assessment and Management of Chronic Pain (NURSING)
- Acute and Post-Operative Pain
- Cancer-related Pain
- Chronic Noncancer Pain
- Comorbid Conditions
- Fibromyalgia
- Headache
- Interventional Modalites
- Low Back Pain
- Medico-Legal-Ethical Issues
- Neuropathic Pain
- Nonopioid Pharmacotherapy
- Nonpharmacologic Treatment
- Opioid Pharmacotherapy
- Osteoarthritis
- Palliative Care
- Risk Management
- Scientific Perspectives
- Special Patient Populations
Editor-in-Chief
Director of the Center for Rehabilitation of Pain Syndromes (CRPS) at the University of California, Los Angeles (UCLA), where he is also a member of the departments of internal medicine and anesthesiology. He is also president of the North American Neuromodulation Society.
Combining his business and medical training, Dr. Prager managed approximately 500,000 patient lives at CIGNA Health Plans and also founded the Multimodality Pain Program. He then directed the UCLA Pain Medicine Center until he established the California Pain Medicine Centers. His clinical and research practice focuses on complex regional pain syndromes and neuromodulation. He has participated in numerous studies related to spinal cord stimulation, intrathecal medications (including ziconotide), and patient programming. He has also conducted research related to several opioids, high-dose capsaicin, and tumor necrosis factor for treatment of complex regional pain syndrome.
Dr. Prager feels that public service is an important component of his career. He helped to establish or reorganize several inner city health centers, provided internal medicine care at the Haight Ashbury Free Medical Clinic in San Francisco, California, and provided anesthesia for third world children with congenital anomalies undergoing corrective surgery. He has held numerous positions in medical organizations. Most recently, Dr. Prager organized the first meeting of a coalition of pain organizations and all 3 manufacturers of spinal cord stimulator systems to collaborate on issues of patient access and reimbursement for neuromodulatory procedures. One goal is to perform studies that will produce evidence-based data to demonstrate the efficacy of these modalities.
Dr. Prager received his MD and a MS in management/heath services research from Stanford University in Palo Alto, California. He is board certified by the American Board of Pain Medicine, the American Board of Internal Medicine, and the American Board of Anesthesiology, with a subspecialty affiliation in pain medicine.
Editor-in-Chief, PAINClincian™
Director
Center for Rehabilitation of Pain Syndromes (CRPS)
University of California, Los Angeles
Department of Internal Medicine and Anesthesiology
David Geffen School of Medicine
University of California, Los Angeles
Los Angeles, California
Douglas Schottenstein, MD, opened his own private practice so that he could deliver the highest quality of care in an advanced, self-contained center. He is one of only 200 physicians in the nation who is double-board certified in neurology and interventional pain management.
Dr Schottenstein and his expert staff at NY Spine Medicine treat patients suffering from a variety of acute and chronic painful conditions. Dr Schottenstein performs a variety of diagnostic and therapeutic procedures and surgeries, including epidurals, transforaminal nerve blocks, sympathetic blocks, facet and sacroiliac joint injections, radiofrequency lesioning, provocative discography, annuloplasty, nucleoplasty, spinal cord stimulation, and intrathecal pumps.
Dr Schottenstein received his interventional pain management training at Columbia University/New York Presbyterian Hospital, rated one of the top five hospitals in the nation. He received his neurology training at Emory University, the highest ranked department in the South, and one of the leading programs in the nation.
In addition to leading NY Spine Medicine, Dr Schottenstein is an attending physician at New York Presbyterian-affiliated hospitals, the top-rated hospital system in the region.
Dr Schottenstein is a highly active member of the American Academy of Neurology, the American Society of Anesthesiology, the American Society of Regional Anesthesia, the International Spine Intervention Society, and the American Society of Interventional Pain Physicians.
Continuing Education Activities
NY Spine Medicine
Attending Physician
New York Presbyterian
New York, New York
Joint Bone Spine. 2011 Oct;78(5):466-70....
Spinal cord stimulation for visceral pain from chronic pancreatitis.
Neuromodulation. 2011 Sep;14(5):423-7.
Spinal cord...
A systematic literature review of psychological characteristics as determinants of outcome for spinal cord stimulation therapy.
Pain. 2010 Aug;150(2):284-9.
Psychological...
Low back pain: an approach to diagnosis and management.
Prim Care. 2010 Dec;37(4):729-41, vi.
Low back pain is a common condition,...
Gamma Knife Stereotactic Radiosurgery in the Management of Cluster Headache.
Curr Pain Headache Rep. 2010 Dec 23.
Gamma...
Neurostimulatory manipulation of cortical signaling is being explored as a potential treatment strategy for chronic pain.
Based on the landmark gate control theory proposed by Ronald Melzack and Patrick D. Wall, spinal cord stimulation is increasingly being used to treat various chronic pain conditions.
Spinal cord stimulation (SCS) has been used for the treatment of a variety of chronic pain conditions. Despite robust benefits for some patients, others do not achieve marked analgesia over time, effects that may be due in part to psychological characteristics of the patients.
Epidural steroid injections are commonly used to treat chronic spinal pain, including axial and radicular pain.
Current diagnostic techniques often fail to identify pain generators in patients with low back pain.
Intraspinal juxtafacet cysts are relatively rare growths that present in patients with various painful conditions, including low back pain, radiculopathy, and neurogenic claudication, among others.